1-20 of 23
Allison M. Winter, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Resource Utilization and Factors Prolonging Hospitalization for Patients with Relapsed and Refractory Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel

Agrima Mian, MBBS, MD, Wei Wei, MS, Brian T. Hill, MD, Betty K. Hamilton, MD, Allison M. Winter, MD, Jack Khouri, MD, Brad Pohlman, MD, Deepa Jagadeesh, MDMPH, Alex V. Mejia Garcia, MD, Faiz Anwer, MD, Aaron T. Gerds, MDMS, Matt Kalaycio, MD, Robert M. Dean, MD, Ronald Sobecks, MD, Navneet S. Majhail, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-137801
Published: 2020
Journal Articles

Results of a Phase I Trial of Lenalidomide, Rituximab (R 2 ) and Ixazomib for Frontline Treatment of High Risk Follicular and Indolent Non-Hodgkin Lymphoma

Brian T. Hill, MD, Deepa Jagadeesh, MDMPH, Alex V. Mejia Garcia, MD, Robert M. Dean, MD, Omer N. Koc, MD, Matt Kalaycio, MD, Kirsten M Boughan, DO, Brenda W. Cooper, MD, Allison M. Winter, MD, Wesam B. Ahmed, MD, Brad Pohlman, MD, Christopher D'Andrea, PA-C, Kelsey Holkovic, RN, Ashley Morrison, RN, Paolo Caimi, MD, Mitchell Smith, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-136370
Published: 2020
Journal Articles

Hematopoietic Progenitor Cell Mobilization and Collection for Autologous Hematopoietic Cell Transplantation in AL Amyloidosis: A Single Center Experience

Anne K Hubben, MD, Lisa Rybicki, MS, Kristin Ricci, MD, Navneet S. Majhail, MD MS, Matt Kalaycio, MD, Betty K. Hamilton, MD, Brian T. Hill, MD, Allison M. Winter, MD, Brad Pohlman, MD, Deepa Jagadeesh, MDMPH, Faiz Anwer, MD, Robert M. Dean, MD, Ronald Sobecks, MD, Chakra P Chaulagain, MD, Hien D. Liu, MD, Jack Khouri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-140456
Published: 2020
Journal Articles

Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies

Anthony R. Mato, MDMSCE, Lindsey E. Roeker, MD, Toby A. Eyre, MBBChir, MRCP, Ryan Jacobs, MD, Brian T. Hill, MD, Nicole Lamanna, MD, Danielle M. Brander, MD, Mazyar Shadman, MD, Chaitra Ujjani, MD, Maryam Yazdy, MD, Guilherme Fleury Perini, MD, Javier Pinilla Ibarz, MD PhD, Jacqueline C Barrientos, MD, Alan Skarbnik, MD, Pallawi Torka, MD, Jeffrey J Pu, MD PhD, John M. Pagel, MD PhD DSc, Satyen Gohil, BSc, MBBS, MRCP, FRCPath, Bita Fakhri, MDMPH, Michael Y. Choi, MD, Catherine C. Coombs, MD, Joanna Rhodes, MD, Paul M. Barr, MD, Craig A. Portell, MD, Helen Parry, MB ChB, MRCP, PhD, Christine Ann Garcia, MD MPH, Kate J Whitaker, BA, Allison M. Winter, MD, Andrea Sitlinger, MD, Sirin Khajavian, MD, Ariel F Grajales-Cruz, MD, Krista Isaac, DO, MS, Pratik Shah, Othman S. Akhtar, MD, Rachael Pocock, MD, Kentson Lam, MD PhD, Timothy J Voorhees, MD, Stephen J. Schuster, MD, Thomas David Rodgers, MD, Nicolas Martinez-Calle, MD MSc, Talha Munir, MD, Erica B Bhavsar, BS, Neil Bailey, MSc, Jason C. Lee, MD, Hanna Weissbrot, BS, Chadi Nabhan, MDMBA, FACP, Julie Goodfriend, Amber C. King, PharmD, BCOP, Andrew D. Zelenetz, MD PhD, Colleen Dorsey, BSN, RN, Kayla Bigelow, Bruce D. Cheson, MD, Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, John N. Allan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 502.
https://doi.org/10.1182/blood-2019-123747
Published: 2019
Journal Articles

Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis

Agrima Mian, MBBS, MD, Wei Wei, MS, Allison M. Winter, MD, Jack Khouri, MD, Deepa Jagadeesh, MDMPH, Faiz Anwer, MD, Aaron T. Gerds, MD MS, Robert M. Dean, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Betty K. Hamilton, MD, Navneet S. Majhail, MD MS, Brian T. Hill, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4452.
https://doi.org/10.1182/blood-2019-127087
Published: 2019
Journal Articles

Survival Outcomes in Patients with Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma According to MYD88 Mutation Status

Agrima Mian, MBBS, MD, Albert Aboseif, DO, Wei Wei, MS, Rajshekhar Chakraborty, MD, Jack Khouri, MD, Joslyn Rudoni, PharmD, Allison M. Winter, MD, Sonam Patel, MD, Deepa Jagadeesh, MDMPH, Robert M. Dean, MD, Brad Pohlman, MD, Stephanie Berg, DO, James R. Cook, MD PhD, Brian T. Hill, MD, Alex V. Mejia Garcia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5248.
https://doi.org/10.1182/blood-2019-130396
Published: 2019
Journal Articles

A Phase I Trial of Venetoclax in Combination with BEAM Conditioning Chemotherapy (V-BEAM) with Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma

Allison M. Winter, MD, Kirsten M Boughan, DO, Jack Khouri, MD, Paolo Caimi, MD, Faiz Anwer, MD, Brenda Cooper, MD, Deepa Jagadeesh, MDMPH, Robert M. Dean, MD, Aaron T. Gerds, MD MS, Ronald Sobecks, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Betty K. Hamilton, MD, Marcos de Lima, MD, Navneet S. Majhail, MD MS, Brian T. Hill, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5705.
https://doi.org/10.1182/blood-2019-124602
Published: 2019
Journal Articles

Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis

Allison M. Winter, MD, Wei Wei, MS, Emily C. Ayers, MD, Daniel J. Landsburg, MD, Saba Raya, MD, Brad S. Kahl, MD, Andrew Rogers, MD MS, Kami J. Maddocks, MD, Mohammad Khan, DO, MSBS, Adam S. Kittai, MD, Alexey Danilov, MD PhD, Chaitra S. Ujjani, MD, Ryan C. Lynch, MD, Loretta J. Nastoupil, MD MSc, Melody R. Becnel, MD, Luke Zurbriggen, MD, Vaishalee P. Kenkre, MD, Sheenu Sheela, MD, Nilanjan Ghosh, MD PhD, Boyu Hu, MD, Deborah M. Stephens, DO, Amy Ayers, MPH, Jonathon B. Cohen, MDMS, Brian T. Hill, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3982.
https://doi.org/10.1182/blood-2019-124783
Published: 2019
Journal Articles

Outcomes of Patients with Relapsed/Refractory Double Expressor B Cell Lymphoma As Defined By Multicenter Pathology Review Treated with Ibrutinib Monotherapy

Daniel J. Landsburg, MD, Mitchell E. Hughes, PharmD, Alexa Koike, David A. Bond, MD, Kami J. Maddocks, MD, Ling Guo, MD, Allison M. Winter, MD, Brian T. Hill, MD PhD, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD, Agata M. Bogusz, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 455.
https://doi.org/10.1182/blood-2018-99-117514
Published: 2018
Journal Articles

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

Allison M. Winter, MD, Loretta J. Nastoupil, MD, Melody R. Becnel, MD, James R. Cerhan, MD PhD, Thomas M. Habermann, MD, Brian K. Link, MD, Matthew J. Maurer, MS, Bita Fakhri, MD MPH, Prathima Reddy, MD, Stephen D. Smith, MD, Dhruvika Mukhija, MD, Deepa Jagadeesh, MD MPH, Amrita Desai, MD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Pooja Mehra, MD, Craig A. Portell, MD, Christopher R. D'Angelo, MD, Vaishalee P. Kenkre, MD, Max L. Goldman, MD, Oscar Calzada, BS, Jonathon B. Cohen, MD MS, Mohammad Junaid Hussain, MD, Nilanjan Ghosh, MD PhD, Yang Liu, MD, Stefan Klaus Barta, MD MRCP, MS, Paolo F Caimi, MD, Adam Kittai, MD, Alexey V Danilov, MD PhD, Timothy Tiutan, MD, Peter Martin, FRCPC, MD MS, Nathalie Danielson, MSN, RN, ACNP-BC, Manali Kamdar, MD, Abhigna Kodali, MD, Andrew M. Evens, DO, MSc, Brad S Kahl, MD, Brian T. Hill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4146.
https://doi.org/10.1182/blood-2018-99-118530
Published: 2018
Journal Articles

Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings

Lindsey E. Roeker, MD, Christopher P. Fox, MD PhD, Toby A. Eyre, John N. Allan, MD, Stephen J. Schuster, MD, Chadi Nabhan, MD, Brian T. Hill, MD PhD, Nirav N Shah, MD, Frederick Lansigan, MD, Maryam Yazdy, MD, Nicole Lamanna, MD, Bruce Cheson, MD, Arun K Singavi, MD, Catherine C. Coombs, MD, Paul Barr, MD, Alan P Skarbnik, MD, Mazyar Shadman, MD MPH, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Allison M. Winter, MD, Joanna Rhodes, MD, Colleen Dorsey, BSN, RN, Hannah Morse, BSN, John M. Pagel, MD PhD, Annalynn M Williams, MS, Ryan Jacobs, MD, Andre Goy, MD, Sivraj Muralikrishnan, MD, Laurie Pearson, MD, Andrea Sitlinger, MD, Neil Bailey, MSc, Anna Schuh, MD PhD, Danielle M. Brander, MD, Amy A Kirkwood, MSc, Anthony R Mato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4410.
https://doi.org/10.1182/blood-2018-99-118159
Published: 2018
Journal Articles

Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, MD PhD, Robert M. Dean, MD, Deepa Jagadeesh, MDMPH, Alex V. Mejia Garcia, MD, Brad Pohlman, MD, Allison M. Winter, MD, Ethan Krauspe, BA, Patrick Collier, MD PhD, Christopher D'Andrea, PA-C, Ashley Morrison, RN, Sarah Lehmann, RN, Benjamin K. Tomlinson, MD, Brenda Cooper, MD, Marcos de Lima, MD, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Paolo Caimi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1692.
https://doi.org/10.1182/blood-2018-99-113381
Published: 2018
Journal Articles

Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration

Deborah M. Stephens, Ken Boucher, PhD, Elizabeth Kander, MD, Sameer A. Parikh, MD, Erin Parry, MD PhD, Mazyar Shadman, MD MPH, John M. Pagel, MD PhD, Jennifer Cooperrider, BA, Joanna Rhodes, MD, Anthony R. Mato, MDMSCE, Allison M. Winter, MD, Brian T. Hill, MD PhD, Sameh Gaballa, MD, Alexey V Danilov, MD PhD, Tycel J. Phillips, MD, Danielle M. Brander, MD, Sonali M. Smith, MD, Matthew S Davids, Kerry A. Rogers, MD, Martha Glenn, MD, John C. Byrd, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1648.
https://doi.org/10.1182/blood-2018-99-113173
Published: 2018
Journal Articles

Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients

Anthony R. Mato, MD MSCE, Lindsey E. Roeker, MD, Toby A. Eyre, Chadi Nabhan, MD, Nicole Lamanna, MD, Brian T. Hill, MD PhD, Danielle M. Brander, MD, Paul Barr, MD, Frederick Lansigan, MD, Bruce Cheson, MD, Arun K Singavi, MD, Maryam Yazdy, MD, Nirav N Shah, MD, John N. Allan, MD, Erica B Bhavsar, BS, Joanna Rhodes, MD, Kaitlin Kennard, RN, BSN, Stephen J. Schuster, MD, Annalynn M Williams, MS, Alan P Skarbnik, MD, Andre Goy, MD, Catherine C. Coombs, MD, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Ryan Jacobs, MD, Allison M. Winter, MD, John M. Pagel, MD PhD, Neil Bailey, MSc, Anna Schuh, MD PhD, Mazyar Shadman, MD MPH, Andrea Sitlinger, MD, Hanna Weissbrot, BS, Sivraj Muralikrishnan, MD, Amy A Kirkwood, MSc, Christopher P. Fox, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3142.
https://doi.org/10.1182/blood-2018-99-114840
Published: 2018
Journal Articles

Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study

Anthony R Mato, MD, Maryam Sarraf Yazdy, MD, Brian T. Hill, MD PhD, Mazyar Shadman, Hande Tuncer, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, John N. Allan, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Chadi Nabhan, MD, Paul Barr, MD, Jennifer R. Brown, MD PhD, Christopher P. Fox, MD PhD, Joanna Rhodes, MD, Anna Schuh, MD PhD, Toby A. Eyre, MD, Nicole Lamanna, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Alan P Skarbnik, MD, Lindsey E. Roeker, MD, Rajat Bannerji, MD PhD, Andrew M. Evens, MD, Frederick Lansigan, MD, Jennifer C. Samp, MS, PharmD, Jacqueline Nielsen, PhD, James M. Pauff, Thomas J. Kipps, MD PhD, Stephen J. Schuster, MD, George A Follows, MD PhD, Bruce Cheson, MD, Barbara Eichhorst
Journal: Blood
Blood (2018) 132 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2018-99-119015
Published: 2018
Journal Articles

Disease and Patient Characteristics, Patterns of Care, Toxicities, and Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax: A Multicenter Study of 204 Patients

Anthony R. Mato, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, John N. Allan, MD, Danielle M. Brander, MD, John M. Pagel, MD PhD, Chaitra S. Ujjani, MD, Brian T. Hill, MD PhD, Nicole Lamanna, MD, Frederick Lansigan, MD, Ryan Jacobs, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Jeffrey J. Pu, MD PhD, Paul M. Barr, MD, Alison R. Sehgal, MD, Bruce D. Cheson, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, Krista Isaac, DO, MS, Colleen Dorsey, BSN, RN, Alexandra Marie Vandegrift, BA, Arun K Singavi, MD, Annalynn Williams, MS, Christina Howlett, PharmD, Hanna Weissbrot, BS, Naveed Ali, MD, Sirin Khajavian, MD, Andrea Sitlinger, MD, Eve Tranchito, BS, Joanna Rhodes, MD, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Bhavisha Patel, MD, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Chadi Nabhan, MD MBA, FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4315.
https://doi.org/10.1182/blood.V130.Suppl_1.4315.4315
Published: 2017
Journal Articles

Real-World Evidence for Durable Treatment Responses after Toxicity Related Discontinuation of Idelalisib

Erin Bange, MD, Chadi Nabhan, MD MBA, FACP, Danielle M. Brander, MD, Nicole Lamanna, MD, Chaitra S. Ujjani, MD, Christina Howlett, PharmD, BCOP, Alan P Skarbnik, MD, Brian T. Hill, MD PhD, Bruce D. Cheson, MD, Clive S Zent, MD, Jeffrey J. Pu, MD PhD, Allison M. Winter, MD, Krista Isaac, DO, MS, Kaitlin Kennard, RN, BSN, Colleen Timlin, PharmD, BCOP, Colleen Dorsey, BSN, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Daniel J. Landsburg, MD, Stephen J. Schuster, MD, Paul M. Barr, MD, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4325.
https://doi.org/10.1182/blood.V130.Suppl_1.4325.4325
Published: 2017
Journal Articles

Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab (BR) for Follicular Lymphoma: A Real World Analysis Across 13 US Cancer Centers

Brian T. Hill, MD PhD, Loretta Nastoupil, MD, Allison M. Winter, MD, Melody R Becnel, MD, James R. Cerhan, MD PhD, Thomas M Habermann, MD, Brian K Link, MD, Matthew J Maurer, MS, Bita Fakhri, MDMPH, Prathima Reddy, MD, Stephen D. Smith, MD, Dhruvika Mukhija, MD, Deepa Jagadeesh, MDMPH, Amrita Desai, MD, Juan Pablo Alderuccio, MD, Izidore S Lossos, MD, Pooja Mehra, MD, Craig A. Portell, MD, Max L. Goldman, BA, Oscar Calzada, BS, Jonathon B Cohen, MDMS, Mohammad Junaid Hussain, MD, Nilanjan Ghosh, MD PhD, Paolo Caimi, MD, Timothy Tiutan, MD, Peter Martin, FRCPC, MD MS, Abhigna Kodali, MD, Andrew M Evens, DO,MSc, Brad S Kahl, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2779.
https://doi.org/10.1182/blood.V130.Suppl_1.2779.2779
Published: 2017
Journal Articles

Front-Line Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in the Real World: Responses, Toxicity, Outcomes and Subsequent Therapies

Anthony R. Mato, MD, John N. Allan, MD, John M. Pagel, MD PhD, Danielle M. Brander, MD, Brian T. Hill, MD PhD, Bruce D. Cheson, MD, Richard R. Furman, MD, Nicole Lamanna, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ryan Jacobs, MD, Frederick Lansigan, MD, Paul M. Barr, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Douglas F. Beach, MD, Jeffrey J. Pu, MD PhD, Alison R. Sehgal, MD, Allison M. Winter, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Arun K Singavi, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Annalynn Williams, MS, Christina Howlett, PharmD, BCOP, Hanna Weissbrot, BS, Naveed Ali, MD, Bhavisha Patel, MD, Krista Isaac, DO, MS, Joanna Rhodes, MD, Mitchell E. Hughes, PharmD, BCPS, BCOP, Sirin Khajavian, MD, Elizabeth T Chatburn, BS, Andrea Sitlinger, MD, Eve Tranchito, BS, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Kaitlin Kennard, RN, BSN, Chadi Nabhan, MD MBA, FACP, Chaitra S. Ujjani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3011.
https://doi.org/10.1182/blood.V130.Suppl_1.3011.3011
Published: 2017
Journal Articles

Toxicities and Outcomes of Ibrutinib-Treated Patients in the United States: Large Retrospective Analysis of 621 Real World Patients

Anthony R. Mato, MDMSCE, Nicole Lamanna, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Brian T. Hill, MD PhD, Christina Howlett, PharmD, BCOP, Alan P Skarbnik, MD, Bruce Cheson, MD, Clive S Zent, MD, Jeffrey J Pu, MD PhD, Pavel Kiselev, PhD, Spencer Henick Bachow, MD, Allison M Winter, MD, Allan-Louie Cruz, MD, David F. Claxton, MD, Catherine Daniel, MD, Krista Isaack, DO, Kaitlin H Kennard, BSN, Colleen Timlin, PharmD, Melissa Yacur, MD, Molly Fanning, BS, Lauren E. Strelec, BA, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, David L Porter, MD, Chadi Nabhan, MD MBA, FACP, Paul Barr, MD
Journal: Blood
Blood (2016) 128 (22): 3222.
https://doi.org/10.1182/blood.V128.22.3222.3222
Published: 2016